By proceeding, you agree to our Terms of Use and Privacy Policy.
OncoImmunity AS is a Norwegian company established to develop bioinformatics software that has the ability to empower precision cancer immunotherapy, and thus improve the outlook for patients with late-stage disease.
26-28 April 2022
For the first time in over two years, we are delighted to be reuniting the neoantigen community in person for the 5th Neoantigen Summit Europe, dedicated to the robust prediction, identification and validation of neoantigens.
Event Ended
Netherlands
Paid
Amsterdam